ES2219853T3 - Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. - Google Patents
Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2219853T3 ES2219853T3 ES98400469T ES98400469T ES2219853T3 ES 2219853 T3 ES2219853 T3 ES 2219853T3 ES 98400469 T ES98400469 T ES 98400469T ES 98400469 T ES98400469 T ES 98400469T ES 2219853 T3 ES2219853 T3 ES 2219853T3
- Authority
- ES
- Spain
- Prior art keywords
- piperidine
- amino
- dihydro
- fumarate
- benzodioxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9702360 | 1997-02-27 | ||
| FR9702360A FR2760014B1 (fr) | 1997-02-27 | 1997-02-27 | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2219853T3 true ES2219853T3 (es) | 2004-12-01 |
Family
ID=9504253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES98400469T Expired - Lifetime ES2219853T3 (es) | 1997-02-27 | 1998-02-27 | Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5968954A (https=) |
| EP (1) | EP0861837B1 (https=) |
| JP (1) | JPH10237071A (https=) |
| CN (1) | CN1090627C (https=) |
| AT (1) | ATE265451T1 (https=) |
| AU (1) | AU725756B2 (https=) |
| BR (1) | BR9800763A (https=) |
| CA (1) | CA2231025C (https=) |
| DE (1) | DE69823411T2 (https=) |
| DK (1) | DK0861837T3 (https=) |
| ES (1) | ES2219853T3 (https=) |
| FR (1) | FR2760014B1 (https=) |
| HU (1) | HU224312B1 (https=) |
| NO (1) | NO314307B1 (https=) |
| NZ (1) | NZ329853A (https=) |
| PL (1) | PL190240B1 (https=) |
| PT (1) | PT861837E (https=) |
| ZA (1) | ZA981680B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| SE0103650D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| NZ535574A (en) * | 2001-01-16 | 2006-07-28 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| ATE424825T1 (de) | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| JP2005343790A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | カルシウムチャネル拮抗薬を含有する医薬組成物 |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| CA2587749A1 (en) * | 2004-12-08 | 2006-06-15 | Astellas Pharma Inc. | Piperidine derivative and process for producing the same |
| UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-02-27 FR FR9702360A patent/FR2760014B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-24 PL PL98324982A patent/PL190240B1/pl not_active IP Right Cessation
- 1998-02-25 JP JP10042716A patent/JPH10237071A/ja active Pending
- 1998-02-25 BR BR9800763-7A patent/BR9800763A/pt not_active Application Discontinuation
- 1998-02-26 HU HU9800422A patent/HU224312B1/hu not_active IP Right Cessation
- 1998-02-26 US US09/031,490 patent/US5968954A/en not_active Expired - Fee Related
- 1998-02-26 CN CN98107709A patent/CN1090627C/zh not_active Expired - Fee Related
- 1998-02-26 CA CA002231025A patent/CA2231025C/fr not_active Expired - Fee Related
- 1998-02-26 NO NO19980803A patent/NO314307B1/no unknown
- 1998-02-26 NZ NZ329853A patent/NZ329853A/xx unknown
- 1998-02-27 ES ES98400469T patent/ES2219853T3/es not_active Expired - Lifetime
- 1998-02-27 AT AT98400469T patent/ATE265451T1/de not_active IP Right Cessation
- 1998-02-27 DK DK98400469T patent/DK0861837T3/da active
- 1998-02-27 EP EP98400469A patent/EP0861837B1/fr not_active Expired - Lifetime
- 1998-02-27 ZA ZA981680A patent/ZA981680B/xx unknown
- 1998-02-27 PT PT98400469T patent/PT861837E/pt unknown
- 1998-02-27 AU AU56359/98A patent/AU725756B2/en not_active Ceased
- 1998-02-27 DE DE69823411T patent/DE69823411T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT861837E (pt) | 2004-07-30 |
| FR2760014A1 (fr) | 1998-08-28 |
| BR9800763A (pt) | 1999-12-07 |
| CN1194983A (zh) | 1998-10-07 |
| NO980803L (no) | 1998-08-28 |
| NO980803D0 (no) | 1998-02-26 |
| CA2231025C (fr) | 2003-09-16 |
| DK0861837T3 (da) | 2004-08-16 |
| HU224312B1 (hu) | 2005-07-28 |
| FR2760014B1 (fr) | 1999-04-09 |
| EP0861837B1 (fr) | 2004-04-28 |
| PL324982A1 (en) | 1998-08-31 |
| HUP9800422A1 (hu) | 1999-12-28 |
| DE69823411T2 (de) | 2005-02-17 |
| DE69823411D1 (de) | 2004-06-03 |
| CN1090627C (zh) | 2002-09-11 |
| US5968954A (en) | 1999-10-19 |
| HU9800422D0 (en) | 1998-04-28 |
| PL190240B1 (pl) | 2005-11-30 |
| JPH10237071A (ja) | 1998-09-08 |
| NZ329853A (en) | 1999-01-28 |
| CA2231025A1 (fr) | 1998-08-27 |
| HK1014945A1 (en) | 1999-10-08 |
| EP0861837A1 (fr) | 1998-09-02 |
| NO314307B1 (no) | 2003-03-03 |
| AU725756B2 (en) | 2000-10-19 |
| ATE265451T1 (de) | 2004-05-15 |
| ZA981680B (en) | 1998-09-04 |
| AU5635998A (en) | 1998-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2223110T3 (es) | Derivados de n-arilpiperidina y su empleo como ligandos del receptor 5-ht1b. | |
| ES2296763T3 (es) | Pirrolidinas disustituidas en 1,3 como amtagonistas de adrenorreceptor alfa-2. | |
| ES2230899T3 (es) | Antagonistas iii receptores de 4-aroil-piperidin-ccr-3. | |
| JP3421323B2 (ja) | ピペリジンｃｃｒ−３受容体拮抗薬 | |
| ES2428751T3 (es) | Derivados de cromona, un procedimiento para su preparación y aplicaciones terapéuticas de los mismos | |
| HUP0101511A2 (hu) | 1-[(1-Szubsztituált-4-piperidinil)-metil]-4-piperidin-származékok, eljárás a vegyületek előállítására, a vegyületeket tartalmazó gyógyászati készítmények és intermedierjeik | |
| JPH07503723A (ja) | ピペラジン及びピペリジン誘導体，並びに抗精神薬としてのこれらの使用 | |
| HUP0203194A2 (hu) | Új fenil-piperazinok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| EP1131321B1 (en) | Indole derivatives and their use as serotonin receptor ligands | |
| ES2219853T3 (es) | Nuevos derivados de 2-aminoindano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| EP1694663A1 (en) | Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder | |
| HRP20000544A2 (en) | 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists | |
| CN103402511B (zh) | 新的苯并间二氧杂环戊烯哌啶化合物 | |
| BRPI0616609A2 (pt) | compostos que têm atividade no receptor m1, composição farmacêutica contendo tais compostos, processo para preparação dos mesmos, bem como seus usos em medicina | |
| PT1663971E (pt) | 2-carbonilamino-6-piperidinaminopiridinas substituídas e 1-carbonilamino-3-piperidinaminobenzenos substituídos como agonistas de 5-ht1f | |
| TWI360540B (en) | Tetrahydroisoquinolylsulphonamide derivatives, the | |
| ES2301979T3 (es) | Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la reabsorcion de serotonina. | |
| Hu et al. | Design, synthesis, and biological evaluation of novel 2-methylpiperazine derivatives as potent CCR5 antagonists | |
| NO316693B1 (no) | Nye indanolforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| KR100825040B1 (ko) | 3-아릴-3-메틸-퀴놀린-2,4-디온 화합물, 약학적으로 허용가능한 이의 염, 이의 제조방법 및 이를 함유하는 약학적조성물 | |
| CN101580487A (zh) | 6-氮杂双环[3.2.1]辛烷-3-取代衍生物及制备方法 | |
| CZ372296A3 (en) | Pharmaceutical compounds | |
| JP4197649B2 (ja) | アデノシン受容体モジュレーターとしてのベンゾチオフェン | |
| ES2357970T3 (es) | Compuestos que tienen actividad en el receptor m1 y sus usos en medicina. |